Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep 26;12(9):e10670.
doi: 10.7759/cureus.10670.

Atypical Case of COVID-19 Associated Kawasaki Disease in an Eight-Year-Old Pakistani Boy

Affiliations
Case Reports

Atypical Case of COVID-19 Associated Kawasaki Disease in an Eight-Year-Old Pakistani Boy

Israr Khan et al. Cureus. .

Abstract

People of all age groups have been affected worldwide during the coronavirus disease 2019 (COVID-19) pandemic. While the global efforts of researchers, clinicians, and scientists are underway, cases involving multiple systems with a wide range of presentations are on the horizon. As health organizations have started warnings about unusual manifestations of a Kawasaki disease (KD)-like inflammatory syndrome associated with COVID-19, some pediatric cardiologists noted that even classic cases are likely going undercounted. Here we report a case of a previously healthy eight-year-old Pakistani boy who presented with a four-day history of low-grade fever. The patient was admitted and diagnosed with COVID-19-associated atypical KD in the setting of fever for more than five days, maculopapular eruptions, and mild conjunctivitis. He screened positive for COVID-19 with an immunoglobulin G titer of 2.1 plus ruling out other childhood illnesses. He was managed with intravenous immunoglobulins and aspirin with gradual resolution of symptoms. His initial echocardiogram was unremarkable. He was discharged home on day six with a follow-up at two weeks.

Keywords: covid-19; kawasaki disease; mucocutaneous lymph node syndrome; sars-cov-2; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Chest x-ray posteroanterior view showing left upper lobe dense area of parenchymal opacification in addition to pleural effusion involving left lower lobe
Figure 2
Figure 2. Chest x-ray posteroanterior view showing patchy infiltrates in the right middle lobe
Figure 3
Figure 3. Daily temperature graph of the patient during hospital stay

References

    1. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Falcini F, Capannini S, Rigante D. Pediatr Rheumatol. 2011;9:17. - PMC - PubMed
    1. Kawasaki disease. Kawasaki T. Proc Japan Acad Ser B. 2006;82:59–71. - PMC - PubMed
    1. Diagnosis and therapy of Kawasaki disease in children. Dajani AS, Taubert KA, Gerber MA, et al. Circulation. 1993;87:1776–1780. - PubMed
    1. Incomplete Kawasaki disease in a child with COVID-19. Rivera-Figueroa EI, Santos R, Simpson S, Garg P. Indian Pediatr. 2020;57:680–681. - PMC - PubMed
    1. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Verdoni L, Mazza A, Gervasoni A, et al. Lancet. 2020;395:1771–1778. - PMC - PubMed

Publication types

LinkOut - more resources